youtube_live
Q2 2027 earnings • in 4 days
See detailschevron_right
DIVISLAB:NSE
Divi's Laboratories Ltd
₹10,064.00
arrow_upward
+1.19%(+118.50) 1D
Nov 3, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DIVISLAB...
Open
₹9,965.00
High
₹10,064.00
Low
₹9,863.00
Mkt. cap
2.67T
Avg. vol.
589.35K
Volume
611.34K
Dividend
0.30%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
91.33
52-wk high
₹10,064.00
52-wk low
₹5,647.50
EPS
₹110.20
Shares outstanding
265.47M
No. of employees
12K
Open
₹9,965.00
High
₹10,064.00
Low
₹9,863.00
Mkt. cap
2.67T
Avg. vol.
589.35K
Volume
611.34K
Dividend
0.30%
Quarterly dividend
₹7.50
Ex-dividend date
Jul 24, 2026
P/E ratio
91.33
52-wk high
₹10,064.00
52-wk low
₹5,647.50
EPS
₹110.20
Shares outstanding
265.47M
No. of employees
12K
News stories
From web sources and news partners
Local 3 News
·
1 hour ago
RAW: NYSE: OPENING BELL (TUESDAY)
Investing News Network
·
Less than a minute ago
NYSE-Affiliated Venue for Tokenization Adds Transfer Agents: NYSE Content Update
Bloomberg.com
·
45 minutes ago
Goldman’s Molavi Says 60% of S&P 500 Is in Bear Market Territory
Fox Business
·
1 hour ago
Midterm elections historically trigger S&P 500 gains 100% of the time
Profile
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization. Wikipedia
About Divi's Laboratories Ltd